| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
33,878 |
31,782 |
$2.78M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
20,935 |
19,610 |
$1.11M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
8,481 |
8,368 |
$487K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
6,787 |
6,682 |
$399K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
6,846 |
6,727 |
$397K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,406 |
3,333 |
$198K |
| 90648 |
|
6,198 |
6,132 |
$118K |
| 99401 |
|
5,035 |
4,851 |
$104K |
| 90670 |
|
4,503 |
4,433 |
$85K |
| 90723 |
|
4,378 |
4,325 |
$83K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
660 |
602 |
$81K |
| 90680 |
|
3,953 |
3,897 |
$75K |
| 96127 |
|
17,135 |
16,541 |
$71K |
| 90686 |
|
3,914 |
3,822 |
$71K |
| 92551 |
|
13,314 |
12,961 |
$61K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
6,437 |
6,342 |
$55K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,367 |
2,366 |
$51K |
| 99173 |
|
15,287 |
14,909 |
$50K |
| 90633 |
|
2,109 |
2,084 |
$40K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,685 |
2,606 |
$35K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
709 |
675 |
$35K |
| 90671 |
|
1,816 |
1,796 |
$35K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,118 |
1,099 |
$29K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
862 |
846 |
$24K |
| 90651 |
|
1,253 |
1,219 |
$23K |
| 83655 |
|
1,449 |
1,433 |
$21K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
243 |
228 |
$19K |
| 90661 |
|
486 |
486 |
$13K |
| 99215 |
Prolong outpt/office vis |
126 |
123 |
$12K |
| 90734 |
|
551 |
534 |
$12K |
| 96132 |
|
112 |
107 |
$10K |
| 94010 |
|
547 |
511 |
$10K |
| 90674 |
|
550 |
539 |
$9K |
| Q3014 |
Telehealth originating site facility fee |
878 |
827 |
$9K |
| 96119 |
|
217 |
199 |
$8K |
| 36416 |
|
3,706 |
3,643 |
$8K |
| 90461 |
|
128 |
126 |
$6K |
| 96120 |
|
217 |
199 |
$6K |
| 90710 |
|
305 |
297 |
$6K |
| 90696 |
|
259 |
253 |
$5K |
| 87807 |
|
451 |
445 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
117 |
116 |
$4K |
| 90700 |
|
203 |
203 |
$4K |
| 90707 |
|
194 |
193 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
257 |
221 |
$4K |
| 90716 |
|
181 |
181 |
$4K |
| 90685 |
|
172 |
172 |
$3K |
| D1206 |
Topical application of fluoride varnish |
146 |
146 |
$3K |
| 96138 |
|
112 |
107 |
$3K |
| 99383 |
|
44 |
40 |
$2K |
| D0145 |
Oral evaluation for a patient under three years of age |
124 |
124 |
$2K |
| 96161 |
|
2,840 |
2,793 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
342 |
313 |
$2K |
| 92015 |
Determination of refractive state |
269 |
261 |
$2K |
| 90620 |
|
94 |
92 |
$2K |
| 99461 |
|
32 |
26 |
$2K |
| 99381 |
|
26 |
24 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
46 |
43 |
$1K |
| 90698 |
|
44 |
37 |
$653.07 |
| 82270 |
|
214 |
178 |
$639.00 |
| 69210 |
|
25 |
14 |
$561.60 |
| 81002 |
|
174 |
163 |
$497.74 |
| 90715 |
|
19 |
15 |
$296.85 |
| 85018 |
|
637 |
627 |
$216.24 |
| 86308 |
|
15 |
14 |
$84.00 |
| 85014 |
|
154 |
153 |
$57.00 |
| 36415 |
Collection of venous blood by venipuncture |
24 |
24 |
$38.40 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
338 |
311 |
$0.00 |
| 99072 |
|
1,730 |
1,523 |
$0.00 |
| 99051 |
|
498 |
488 |
$0.00 |
| 96160 |
|
250 |
244 |
$0.00 |